Clinicopathological relevance of BRAF mutations in human cancer

S Pakneshan, A Salajegheh, RA Smith… - Pathology-Journal of …, 2013 - journals.lww.com
BRAF represents one of the most frequently mutated protein kinase genes in human
tumours. The mutation is commonly tested in pathology practice. BRAF mutation is seen in …

NCCN guidelines insights: thyroid carcinoma, version 2.2018

RI Haddad, C Nasr, L Bischoff, NL Busaidy… - Journal of the National …, 2018 - jnccn.org
The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the
management of different types of thyroid carcinoma, including papillary, follicular, Hürthle …

[HTML][HTML] Opportunities and challenges of liquid biopsy in thyroid cancer

C Romano, F Martorana, MS Pennisi, S Stella… - International journal of …, 2021 - mdpi.com
Thyroid cancer is the most common malignancy of the endocrine system, encompassing
different entities with distinct histological features and clinical behavior. The diagnostic …

[PDF][PDF] Guidelines for the management of thyroid cancer.

P Perros, K Boelaert, S Colley, C Evans… - Clinical …, 2014 - thyroidcancercanada.org
BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients

L Yip, MN Nikiforova, JY Yoo, KL McCoy… - Annals of …, 2015 - journals.lww.com
Objectives: To correlate thyroid cancer genotype with histology and outcomes. Background:
The prognostic significance of molecular signature in thyroid cancer (TC) is undefined but …

Molecular variants and their risks for malignancy in cytologically indeterminate thyroid nodules

WS Goldner, TE Angell, SL McAdoo, J Babiarz… - Thyroid, 2019 - liebertpub.com
Background: Gene panels are routinely used to assess predisposition to hereditary cancers
by simultaneously testing multiple susceptibility genes and/or variants. More recently …

Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules

EJ de Koster, LF de Geus-Oei, OM Dekkers… - Endocrine …, 2018 - academic.oup.com
Indeterminate thyroid cytology (Bethesda III and IV) corresponds to follicular-patterned
benign and malignant lesions, which are particularly difficult to differentiate on cytology …

BRAFV600E mutation as a predictor of thyroid malignancy in indeterminate nodules: A systematic review and meta-analysis

M Jinih, N Foley, O Osho, L Houlihan, AA Toor… - European Journal of …, 2017 - Elsevier
Background Thyroid nodules are usually diagnosed using fine-needle aspiration (FNA). The
sensitivity limitations of FNA result in 10–30% of nodules being classified as “indeterminate” …

Molecular markers for the classification of cytologically indeterminate thyroid nodules

M Muzza, C Colombo, G Pogliaghi… - Journal of …, 2020 - Springer
Background The diagnosis of indeterminate lesions of the thyroid is a challenge in
cytopathology practice. Indeed, up to 30% of cases lack the morphological features needed …

Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy

EJ Ha, JH Baek, JH Lee, DE Song, JK Kim, YK Shong… - Thyroid, 2013 - liebertpub.com
Purpose: To evaluate the diagnostic role of core needle biopsy (CNB) in sonographically
suspicious thyroid nodules with initially benign cytologic results through a histologic analysis …